Cybin Inc (NY: CYBN )
0.2550
-0.0012
(-0.47%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Cybin Inc
![](https://mms.businesswire.com/media/20240214652029/en/1908939/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240207711728/en/1908939/22/Cybin_Side_Logo.jpg)
Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
February 07, 2024
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/Psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Advanced-Technology-Clinic-DMT-Psilocybi.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240123732289/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/13/psyched_new_-_option_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/12/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/10/photo_trailblazers_dall-e_2.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/08/advanced_technology_clinic_dmt_psilocybin_mdma_aiyoshi597_bacsica_gisele_yashar_and_gorodenkoff_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240108181308/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/06/maps_blue.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240104932138/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/psychedelic_image.png?width=1200&height=800&fit=crop)
Psychedelic Stock Gainers And Losers From January 1, 2024
January 01, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/10/psychedelic-stocks-a-1600.jpg)
![](https://mms.businesswire.com/media/20231206873079/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/04/psyched.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231205340649/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/01/psychedelic_intellectual_property_photon_photo_and_jynto_on_wikimedia_commons.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231130470838/en/1956379/5/CYBN_Topline_Data_Presentation_-_Nov_30_2023_-_3000_px.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/22/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/psychedelic_image.png?width=1200&height=800&fit=crop)
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
November 23, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.